Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 3
1996 3
1997 5
1998 6
1999 1
2000 2
2001 3
2002 6
2003 7
2004 9
2005 13
2006 11
2007 12
2008 11
2009 3
2010 3
2011 2
2012 4
2013 3
2014 5
2015 2
2016 2
2017 2
2018 5
2020 3
2022 2
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease.
Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S, Dent G, Hansson O, Harrison K, von Hehn C, Iwatsubo T, Mallinckrodt C, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajagovindan R, Skordos L, Tian Y, van Dyck CH, Vellas B, Wu S, Zhu Y, Sandrock A. Budd Haeberlein S, et al. Among authors: mallinckrodt c. J Prev Alzheimers Dis. 2022;9(2):197-210. doi: 10.14283/jpad.2022.30. J Prev Alzheimers Dis. 2022. PMID: 35542991 Clinical Trial.
Investigating Partially Discordant Results in Phase 3 Studies of Aducanumab.
Mallinckrodt C, Tian Y, Aisen PS, Barkhof F, Cohen S, Dent G, Hansson O, Harrison K, Iwatsubo T, Mummery CJ, Muralidharan KK, Nestorov I, Nisenbaum L, Rajagovindan R, von Hehn C, van Dyck CH, Vellas B, Wu S, Zhu Y, Sandrock A, Chen T, Budd Haeberlein S. Mallinckrodt C, et al. J Prev Alzheimers Dis. 2023;10(2):171-177. doi: 10.14283/jpad.2023.6. J Prev Alzheimers Dis. 2023. PMID: 36946443 Clinical Trial.
Using principal stratification in analysis of clinical trials.
Lipkovich I, Ratitch B, Qu Y, Zhang X, Shan M, Mallinckrodt C. Lipkovich I, et al. Among authors: mallinckrodt c. Stat Med. 2022 Aug 30;41(19):3837-3877. doi: 10.1002/sim.9439. Epub 2022 Jun 13. Stat Med. 2022. PMID: 35851717
"Time Saved" Calculations to Improve Decision-Making in Progressive Disease Studies.
Dickson SP, Haaland B, Mallinckrodt CH, Dubois B, O'Keefe P, Morgan M, Peters O, Fernández Santana Iii A, Harrison J, Schneeberger A, Hendrix S. Dickson SP, et al. Among authors: mallinckrodt ch. J Prev Alzheimers Dis. 2024;11(3):529-536. doi: 10.14283/jpad.2024.64. J Prev Alzheimers Dis. 2024. PMID: 38706269 Free PMC article. Clinical Trial.
The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease.
Mohs RC, Beauregard D, Dwyer J, Gaudioso J, Bork J, MaGee-Rodgers T, Key MN, Kerwin DR, Hughes L, Cordell CB; Bio‐Hermes Collaborative Group. Mohs RC, et al. Alzheimers Dement. 2024 Apr;20(4):2752-2765. doi: 10.1002/alz.13722. Epub 2024 Feb 28. Alzheimers Dement. 2024. PMID: 38415908 Free PMC article.
Analyzing incomplete longitudinal clinical trial data.
Molenberghs G, Thijs H, Jansen I, Beunckens C, Kenward MG, Mallinckrodt C, Carroll RJ. Molenberghs G, et al. Among authors: mallinckrodt c. Biostatistics. 2004 Jul;5(3):445-64. doi: 10.1093/biostatistics/5.3.445. Biostatistics. 2004. PMID: 15208205
126 results